NanoViricides Inc. (NNVC): But now Theracour is allowing NNVC to s...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Tuesday, 11/20/2018 1:19:32 PM

Tuesday, November 20, 2018 1:19:32 PM

But now Theracour is allowing NNVC to skip payments for 6 months, allowing a fairly serious dept to pile up.

Can you quote the words that say this? All I see is this:

TheraCour has agreed to defer $25,000 per month of development fees for six months, beginning with July 2018

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Keep Last Read

Replies (2) Next 10 Prev Next

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM

InvestorsHub NewsWire

Only $200 per official company press release!